35911759|t|Extracellular Vesicles From Hyperammonemic Rats Induce Neuroinflammation in Cerebellum of Normal Rats: Role of Increased TNFalpha Content.
35911759|a|Hyperammonemia plays a main role in the neurological impairment in cirrhotic patients with hepatic encephalopathy. Rats with chronic hyperammonemia reproduce the motor incoordination of patients with minimal hepatic encephalopathy, which is due to enhanced GABAergic neurotransmission in cerebellum as a consequence of neuroinflammation. Extracellular vesicles (EVs) could play a key role in the transmission of peripheral alterations to the brain to induce neuroinflammation and neurological impairment in hyperammonemia and hepatic encephalopathy. EVs from plasma of hyperammonemic rats (HA-EVs) injected to normal rats induce neuroinflammation and motor incoordination, but the underlying mechanisms remain unclear. The aim of this work was to advance in the understanding of these mechanisms. To do this we used an ex vivo system. Cerebellar slices from normal rats were treated ex vivo with HA-EVs. The aims were: 1) assess if HA-EVs induce microglia and astrocytes activation and neuroinflammation in cerebellar slices of normal rats, 2) assess if this is associated with activation of the TNFR1-NF-kB-glutaminase-GAT3 pathway, 3) assess if the TNFR1-CCL2-BDNF-TrkB pathway is activated by HA-EVs and 4) assess if the increased TNFalpha levels in HA-EVs are responsible for the above effects and if they are prevented by blocking the action of TNFalpha. Our results show that ex vivo treatment of cerebellar slices from control rats with extracellular vesicles from hyperammonemic rats induce glial activation, neuroinflammation and enhance GABAergic neurotransmission, reproducing the effects induced by hyperammonemia in vivo. Moreover, we identify in detail key underlying mechanisms. HA-EVs induce the activation of both the TNFR1-CCL2-BDNF-TrkB-KCC2 pathway and the TNFR1-NF-kB-glutaminase-GAT3 pathway. Activation of these pathways enhances GABAergic neurotransmission in cerebellum, which is responsible for the induction of motor incoordination by HA-EVs. The data also show that the increased levels of TNFalpha in HA-EVs are responsible for the above effects and that the activation of both pathways is prevented by blocking the action of TNFalpha. This opens new therapeutic options to improve motor incoordination in hyperammonemia and also in cirrhotic patients with hepatic encephalopathy and likely in other pathologies in which altered cargo of extracellular vesicles contribute to the propagation of the pathology.
35911759	28	42	Hyperammonemic	Disease	
35911759	43	47	Rats	Species	10116
35911759	55	72	Neuroinflammation	Disease	MESH:D000090862
35911759	97	101	Rats	Species	10116
35911759	121	129	TNFalpha	Gene	24835
35911759	139	153	Hyperammonemia	Disease	MESH:D022124
35911759	179	202	neurological impairment	Disease	MESH:D009422
35911759	206	215	cirrhotic	Disease	MESH:D000094724
35911759	216	224	patients	Species	9606
35911759	230	252	hepatic encephalopathy	Disease	MESH:D006501
35911759	254	258	Rats	Species	10116
35911759	272	286	hyperammonemia	Disease	MESH:D022124
35911759	301	321	motor incoordination	Disease	MESH:D002524
35911759	325	333	patients	Species	9606
35911759	347	369	hepatic encephalopathy	Disease	MESH:D006501
35911759	458	475	neuroinflammation	Disease	MESH:D000090862
35911759	597	614	neuroinflammation	Disease	MESH:D000090862
35911759	619	642	neurological impairment	Disease	MESH:D009422
35911759	646	660	hyperammonemia	Disease	MESH:D022124
35911759	665	687	hepatic encephalopathy	Disease	MESH:D006501
35911759	708	722	hyperammonemic	Disease	
35911759	723	727	rats	Species	10116
35911759	756	760	rats	Species	10116
35911759	768	785	neuroinflammation	Disease	MESH:D000090862
35911759	790	810	motor incoordination	Disease	MESH:D002524
35911759	1004	1008	rats	Species	10116
35911759	1125	1142	neuroinflammation	Disease	MESH:D000090862
35911759	1174	1178	rats	Species	10116
35911759	1235	1240	TNFR1	Gene	25625
35911759	1241	1246	NF-kB	Gene	309165
35911759	1247	1258	glutaminase	Gene	24398
35911759	1259	1263	GAT3	Gene	79213
35911759	1290	1295	TNFR1	Gene	25625
35911759	1296	1300	CCL2	Gene	24770
35911759	1301	1305	BDNF	Gene	24225
35911759	1306	1310	TrkB	Gene	25054
35911759	1373	1381	TNFalpha	Gene	24835
35911759	1489	1497	TNFalpha	Gene	24835
35911759	1573	1577	rats	Species	10116
35911759	1611	1625	hyperammonemic	Disease	
35911759	1626	1630	rats	Species	10116
35911759	1656	1673	neuroinflammation	Disease	MESH:D000090862
35911759	1750	1764	hyperammonemia	Disease	MESH:D022124
35911759	1874	1879	TNFR1	Gene	25625
35911759	1880	1884	CCL2	Gene	24770
35911759	1885	1889	BDNF	Gene	24225
35911759	1890	1894	TrkB	Gene	25054
35911759	1895	1899	KCC2	Gene	171373
35911759	1916	1921	TNFR1	Gene	25625
35911759	1922	1927	NF-kB	Gene	309165
35911759	1928	1939	glutaminase	Gene	24398
35911759	1940	1944	GAT3	Gene	79213
35911759	2077	2097	motor incoordination	Disease	MESH:D002524
35911759	2157	2165	TNFalpha	Gene	24835
35911759	2294	2302	TNFalpha	Gene	24835
35911759	2350	2370	motor incoordination	Disease	MESH:D002524
35911759	2374	2388	hyperammonemia	Disease	MESH:D022124
35911759	2401	2410	cirrhotic	Disease	MESH:D000094724
35911759	2411	2419	patients	Species	9606
35911759	2425	2447	hepatic encephalopathy	Disease	MESH:D006501
35911759	Association	24225	25625
35911759	Association	24398	309165
35911759	Association	24770	25054
35911759	Association	24770	25625
35911759	Association	24225	25054
35911759	Association	24398	79213
35911759	Association	25625	309165
35911759	Association	171373	24225
35911759	Association	25054	25625
35911759	Association	24398	25625
35911759	Association	24225	24770
35911759	Association	309165	79213
35911759	Association	25625	79213
35911759	Association	171373	25054

